Literature DB >> 22833955

Personalized medicine: the impact on chemistry.

John Watkins1, Andrew Marsh, Paul C Taylor, Donald R J Singer.   

Abstract

An effective strategy for personalized medicine requires a major conceptual change in the development and application of therapeutics. In this article, we argue that further advances in this field should be made with reference to another conceptual shift, that of network pharmacology. We examine the intersection of personalized medicine and network pharmacology to identify strategies for the development of personalized therapies that are fully informed by network pharmacology concepts. This provides a framework for discussion of the impact personalized medicine will have on chemistry in terms of drug discovery, formulation and delivery, the adaptations and changes in ideology required and the contribution chemistry is already making. New ways of conceptualizing chemistry's relationship with medicine will lead to new approaches to drug discovery and hold promise of delivering safer and more effective therapies.

Mesh:

Substances:

Year:  2010        PMID: 22833955     DOI: 10.4155/tde.10.64

Source DB:  PubMed          Journal:  Ther Deliv        ISSN: 2041-5990


  4 in total

Review 1.  Nanomedicines based on recombinant fusion proteins for targeting therapeutic siRNA oligonucleotides.

Authors:  Johannes Winkler
Journal:  Ther Deliv       Date:  2011-07

2.  Exploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome--clozapine-induced agranulocytosis as a case study.

Authors:  Lun Yang; Kejian Wang; Jian Chen; Anil G Jegga; Heng Luo; Leming Shi; Chunling Wan; Xizhi Guo; Shengying Qin; Guang He; Guoyin Feng; Lin He
Journal:  PLoS Comput Biol       Date:  2011-03-31       Impact factor: 4.475

Review 3.  Clinical Perspectives on Targeting Therapies for Personalized Medicine.

Authors:  Donald R J Singer; Zoulikha M Zaïr
Journal:  Adv Protein Chem Struct Biol       Date:  2015-12-29       Impact factor: 3.507

4.  Integrated in Silico and Experimental Approach towards the Design of a Novel Recombinant Protein Containing an Anti-HER2 scFv.

Authors:  Joana Santos; Miguel Cardoso; Irina S Moreira; João Gonçalves; João D G Correia; Sandra Cabo Verde; Rita Melo
Journal:  Int J Mol Sci       Date:  2021-03-29       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.